Accure Health ("Accure") is a privately held, next-generation precision medicine company. Accure is focused on developing AI-powered, integrated solutions that leverage patients' biomarker profiles to enable precision therapies delivered to the right cells for the right patients. Accure’s motto is "Cure through Accuracy".
Accure’s founders bring together a wealth of cross-functional expertise applying technology to clinical challenges. Collectively, they have made significant contributions to advancing the early disease detection and therapeutic development through innovations in bioengineering and data sciences at leading academic institutions and in industry.
partners & Ecosystem
Accure is proud to partner with leading academic centers and government agencies to fulfill our mission of empowering precision health. Accure has been supported by the prestigious Pagliuca Harvard Life Lab, the Engine Built by MIT, the LabCentral, the Natonal Cancer Institute, the SBIR program, and the Massachusetts Life Sciences Center.